SCHEMBL6201333

SCHEMBL6201333

CCOC(=O)c1c(NC(=O)CN2CCCCC2)sc2c1CCC(C(C)(C)C)C2

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.65
MAPT P10636 7/20 0.65
TP53 P04637 5/20 0.65
MEN1 O00255 4/20 0.65
KMT2A Q03164 4/20 0.65
TSHR P16473 3/20 0.65
SMN1; SMN2 Q16637 3/20 0.65
HPGD P15428 2/20 0.65
NPSR1 Q6W5P4 2/20 0.65
THRB P10828 2/20 0.61
HSD17B10 Q99714 4/20 0.59
MAPK1 P28482 2/20 0.59
ALOX15 P16050 1/20 0.59
LMNA P02545 3/20 0.58
USP2 O75604 2/20 0.57
POLB P06746 1/20 0.57
HTT P42858 2/20 0.53
KDM4E B2RXH2 2/20 0.50
GAA P10253 1/20 0.50
CYBB P04839 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6203815 0.83 ALDH1A1 (0.79) ALDH1A1MAPTTP53MEN1KMT2A
SCHEMBL6202090 0.83 ALDH1A1 (0.79) ALDH1A1MAPTTP53MEN1KMT2A
SCHEMBL6203156 0.83 ALDH1A1 (0.82) ALDH1A1MAPTTP53MEN1KMT2A
SCHEMBL6200055 0.83 ALDH1A1 (0.82) ALDH1A1MAPTTP53MEN1KMT2A
SCHEMBL918255 0.83 KDM4E (0.66) ALDH1A1MAPTTP53MEN1KMT2A
SCHEMBL6204554 0.82 ALDH1A1 (0.61) ALDH1A1MAPTTP53MEN1KMT2A
SCHEMBL6203540 0.82 ALDH1A1 (0.80) ALDH1A1MAPTTP53MEN1KMT2A
SCHEMBL6205044 0.82 ALDH1A1 (0.84) ALDH1A1MAPTTP53MEN1KMT2A
SCHEMBL6203802 0.82 ALDH1A1 (0.66) ALDH1A1MAPTTP53MEN1KMT2A
SCHEMBL6203821 0.80 ALDH1A1 (0.84) ALDH1A1MAPTTP53MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1509514-A1 ANTHELMINTIC AND INSECTICIDAL THIOPHENE DERIVATIVES PHARMACIA & UPJOHN COMPANY (US) 2005-03-02 EP claimed
US-20040014740-A1 Novel anthelmintic and insecticidal compositions PHARMACIA & UPJOHN COMPANY 2004-01-22 US claimed
WO-2003101979-A1 ANTHELMINTIC AND INSECTICIDAL THIOPHENE DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2003-12-11 WO claimed
EP-1509514-A1 ANTHELMINTIC AND INSECTICIDAL THIOPHENE DERIVATIVES PHARMACIA & UPJOHN COMPANY (US) 2005-03-02 EP disclosed
US-20040014740-A1 Novel anthelmintic and insecticidal compositions PHARMACIA & UPJOHN COMPANY 2004-01-22 US disclosed
WO-2003101979-A1 ANTHELMINTIC AND INSECTICIDAL THIOPHENE DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2003-12-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040014740-A1 Novel anthelmintic and insecticidal compositions ACHE, BCHE, AADAC ALDH1A1 2781/4885MAPT 2875/4885TP53 4828/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.